Andrew Siderowf
University of Pennsylvania · 16 works · 1,111 citations · h-index 6
Top works
- Neuro-QOL
- Gastrostomy insertion in ALS patients with low vital capacity: Respiratory support and survival
- Breaking the news: A survey of ALS patients and their caregivers
- Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging
- Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)
- Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder
- [O5–01–01]: PET BIOMARKERS IN THE EXPEDITION 3 TRIAL OF PATIENTS WITH MILD AD
- P4‐314: TEST‐RETEST DATA FOR THE TAU PET IMAGING AGENT 18F‐AV‐1451 (PREVIOUSLY, 18F‐T807)
- Reliability of visual interpretation of 5 min and 10 min florbetapir F18 scans from ADNI database
- Differential Levodopa Responsiveness and Motor Complication Trajectories in Parkinson’s Disease by α-Synuclein Seed Amplification Assay Status
- Ongoing development of analysis strategies with [F-18]-T807 (AV-1451): A PET biomarker for tau deposits
- O4‐01‐02: EFFECT OF AMYLOID IMAGING ON DIAGNOSIS AND MANAGEMENT OF PATIENTS WITH COGNITIVE DECLINE: IMPACT OF APPROPRIATE USE CRITERIA
- Supplementary Material for: Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use Criteria
- O4‐07‐01: Evolution of [18F]Av‐1451 Pet Tau Signal: Interim Analysis of an 18‐Month Phase 2 Study
- Supplementary Material for: Effectiveness of Florbetapir PET Imaging in Changing Patient Management